Jennifer Humes
Vermögen: 4 Mio $ am 30.06.2026
Vermögen: 4 Mio $ am 30.06.2026
Jennifer Humes currently works at Roivant Sciences Ltd., as Chief Accounting Officer from 2025 and Roivant Sciences, Inc., as Chief Accounting Officer from 2025.
Ms. Humes also formerly worked at JPMorgan Chase & Co., as Controller-Global Investment Banking in 2024.
Ms. Humes received her undergraduate degree from the University of St. Thomas.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.06.2026 | 109’782 ( 0.02% ) | 4 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ROIVANT SCIENCES LTD. | Comptroller/Controller/Auditor | 20.02.2025 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Comptroller/Controller/Auditor | 20.02.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01.12.2024 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
JPMorgan Chase & Co.
JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
University of St. Thomas
University of St. Thomas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen